David Su is a founding managing partner at Matrix Partners China, focused primarily on software, technology and healthcare investments.
David has been investing in China for the last two decades and some of his investments include Didi Chuxing (NSDQ:DIDI), Baidu (NSDQ:BIDU), Bona Film (NSDQ:BONA), Focus Media (NSDQ:FMCN), Kanghui Medical (NYSE:KH), Kingfriend Biochemical (SS:603707), China Youzan (8083.HK), AAC Technologies (2018.HK), Heptagon (SIX:AMS).
Before Matrix, David was a founding general partner of TDF Capital and KPCB China. Prior to joining the venture capital industry, David worked at Lotus Development, IBM Software Group for seven years and was last responsible for Lotus’ software and services business in Greater China region. David graduated with a Bachelor of Applied Science in Computer Engineering from Nanyang Technological University, Singapore.
David is a Fellow of the inaugural class of the China Fellowship Program and a member of the Aspen Global Leadership Network. He also co-founded San Si Institute, a community of high achieving entrepreneurial leaders in China who are committed to tackle the big challenges of our society.